Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Niacinamide + saccharide isomerate is a topical cosmetic/dermatologic combination of vitamin B3 (niacinamide) with a carbohydrate complex humectant (saccharide isomerate) designed primarily for skin hydration, barrier support, and soothing. Niacinamide reduces transepidermal water loss, improves barrier lipid synthesis, and has anti-inflammatory and tone-evening effects, while saccharide isomerate mimics the skin’s natural moisturizing factor to bind water in the stratum corneum and provide long-lasting hydration and barrier reinforcement.[1][2] This combination is used in moisturizers, serums, and acne- or brightening-focused skincare products to support barrier repair, decrease dryness and irritation, and enhance overall skin smoothness and suppleness.[1][2][5][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on niacinamide + saccharide isomerate.